tm
Seeing Is Believing
tm
Seeing Is Believing
with an average price target of $13.32. This is a potential upside of $13.32 (0%) from yesterday's end of day stock price of $0.
Travere Therapeutics's activity chart (see below) currently has 23 price targets and 15 ratings on display.
Analysts average stock forecasts to be materialized ratio is 35% with an average time for these price targets to be met of 289.63 days.
Most recent stock forecast was given by DO KIM from PIPER SANDLER on 06-Nov-2020. First documented stock forecast 30-Mar-2015.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$31
4 years 2 months 17 days ago
(06-Nov-2020)
3/10 (30%)
$11.15 (56.17%)
415
Buy
$36
$11.34 (45.99%)
$33
4 years 2 months 18 days ago
(06-Nov-2020)
0/2 (0%)
$13.59 (64.93%)
Buy
$30
$5.34 (21.65%)
$19
4 years 5 months ago
(24-Aug-2020)
2/4 (50%)
$9.66 (55.92%)
217
Buy
$38
$13.34 (54.10%)
$44
4 years 5 months 26 days ago
(29-Jul-2020)
0/2 (0%)
$18.1 (79.97%)
Hold
$19
$-5.66 (-22.95%)
$20
4 years 10 months 30 days ago
(25-Feb-2020)
2/2 (100%)
$5.77 (42.48%)
217
What is RTRX (Travere Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on RTRX (Travere Therapeutics) with a proven track record?
Which analyst has the current lower performing score on RTRX (Travere Therapeutics) with a proven track record?
Which analyst has the most public recommendations on RTRX (Travere Therapeutics)?
Which analyst is the currently most bullish on RTRX (Travere Therapeutics)?
Which analyst is the currently most reserved on RTRX (Travere Therapeutics)?
